|
|
Welcome to the Zap VAP newsroom.
 At Covidien, we're passionate about making doctors, nurses, pharmacists and other medical professionals as effective as they can be.
Through ongoing collaboration with medical professionals and organizations, we identify clinical needs and translate them into proven products and procedures.
Watch for additional features to this site in coming weeks.
|
|
03 December 2008
Covidien’s Hi-Lo Evac™ Endotracheal Tube Selected for Premier QUEST Comparative Innovation Program
BOULDER, CO - Dec. 3, 2008 – Covidien, a leading global provider of healthcare products, today announced that its Hi-Lo Evac™ endotracheal tube was named part of Premier Healthcare Alliance’s QUEST Comparative Innovation Program (CIP). The Hi-Lo Evac tube, which facilitates continuous aspiration of subglottic secretions (CASS) to reduce ventilator-associated pneumonia (VAP), was selected based on clinical evidence and potential impact on the five QUEST measurement areas – mortality, cost of care, evidence-based care, patient experience and harm avoidance. (more)
|
|
|
16 June 2008
Covidien Announces New Program to Recognize Reduced VAP Infection Rates
Covidien (NYSE: COV, BSX: COV), a leading global healthcare products company and recognized innovator in mechanical ventilation and respiratory care devices, today announced the Zap VAP Recognition Program. This program will publicly recognize hospitals that have successfully reduced their ventilator-associated pneumonia (VAP) rates.
All Zap VAP Centers of Excellence will be recognized at a reception held at the annual conference of the Association for Professionals in Infection Control (APIC) in Denver on June 16. Special recognition is planned for those facilities that have achieved a zero-VAP rate over the last 12 months in at least one clinical unit. (more)
|
| |
Get more news stories here...
|
|
|
